|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
��ɫ���� |
|
���� |
| ��������������� | |
|
��ӱ |
|
�Ӣ |
|
������ |
| PubMed | |
|
Article by |
|
Article by |
|
Article by |
�����������Ƥ���������Ľ�չ
��ӱ, �Ӣ, ������
���ľ�ҽ��ѧ����ҽԺȫ��Ƥ���Բ�����, ���� 710032
Ƥ�����Ժ���������Ƥ������ϸ��ϵͳ��������һ�ֶ�������,Լռ����������1%��3%.�ڹ�ȥ��10����,�䷢������������������.���������˶��Ժ��������ٴ����ڡ�����������ơ��ܰʹ����γ����͵���������䶳���Ƶ�.������Ϻ���������г�Ϊ����ԭ���Զ��Ժ������������Ʒ�.
[2] Roses DF, Harris MN, Rigel D, et al. Local and in-transit metastases following definitive excision for primary cutaneous malignant melanoma. Ann Surg, 1983, 198(1):65-69.
[3] Moehrle M, Metzger S, Schippert W,et al. "Functional" surgery in subunguai melanoma. Dermatol Surg, 2003, 29(4):366-374.
[4] Nagi C, OGrady TC, Izadpanah A. Mohs micrographically controlled surgery and the treatment of malignant melanoma. Semin Oncol,2002, 29(4):336-340.
[5] Bienert TN, Trotter M J, Arlette JP. Treatment of cutaneous melanoma of the face by Mohs micrographic surgery. J Cutan Med Surg, 2003, 7(1):25-30.
[6] Zitelli JA, Brown CD, Hanusa BH. Surgical margins for excision of primary cutaneous melanoma. J Am Acad Dermatol, 1997, 37(3 Pt 1):422-429.
[7] Brown CD, Zitelli JA. The prognosis and treatment of true local cutaneous recurrent malignant melanoma. Dermatol Surg, 1995, 21(4):285-290.
[8] McMasters KM, Sondak VK, Lotze MT, et al. Recent advances in melanoma staging and therapy. Ann Surg Oncol, 1999, 6(5):467.
[9] Statius Muller MG, Hennipman FA, van Leeuwen PA, et al. Unpredictability of lymphatic drainage patterns in melanoma patients. Eur J Nucl Med Mol Imaging, 2002, 29(2):255-261.
[10] Statius Muller MG, van Leeuwen PA, de Lange-De Klerk ES, et al.The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage �� or �� cutaneous melanoma.Cancer, 2001, 91(12):2401-2408.
[11] Medina-Franco H, Beenken SW, Heslin MJ, et al. Sentinel node biopsy for cutaneous melanoma in the head and neck. Ann Surg Oncol,2001,8(9):716-719.
[12] Jansen L, Nieweg OE, Peterse JL, et al. Reliability of sentinel lymph node biopsy for staging melanoma. Br J Surg, 2000, 87(4):484.
[13] Blaheta HJ, Ellwanger U, Schittek B, et al. Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma. J Invest Dermatol, 2000, 114(4):637-642.
[14] van der Velde-Zimmermann D, Schipper ME, de Weger RA, et al.Sentinel node biopsies in melanoma patients:a protocol for accurate,efficient, and cost-effective analysis by preselection for immunohistochemistry on the basis of Tyr-PCR. Ann Surg Oncol, 2000, 7(1):51.
[15] Corsetti RL, Allen HM, Wanebo HJ. Thin
[17] Karakousis CP, Grigoropoulos P. Sentinel node biopsy before and after wide excision of the primary melanoma. Ann Surg Oncol, 1999, 6(8):785-789.
[18] Starz H, Balda BR, Kramer KU, et al. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer, 2001, 91(11):2110-2121.
[19] Sheridan AT, Dawber RP. Curettage, electrosurgery and skin cancer.Australas J Dermatol, 2000, 41(1):19-30.
[20] Goldman G. The current status of curettage and electrodesiccation.Dermatol Clin, 2002, 20(3):569-578.
[21] Kuflik EG, Gage AA. Cryosurgery for lentigo maligna. J Am Acad Dermatol, 1994, 31(1):75-78.
[22] Mir LM, Rubinsky B. Treatment of cancer with cryochemotherapy. Br J Cancer, 2002, 86(10):1658-1660.